A*STAR Bioprocessing Technology Institute (A*STAR BTI)

New insights on heat and acidity’s role in monoclonal antibody clumping pave the way for improved biotherapeutics production methods.

A study on how animal meats and their plant-based alternatives are digested uncover key nutritional differences with implications for future food innovation.

Combining engineering precision and data-driven insights, Charmaine Chia builds miniature technologies that unlock groundbreaking solutions for biotechnology.

Cell and gene therapies are driving the next revolution in medicine, combining the best of biology with game-changing technologies from A*STAR researchers and partners.

A*STAR researchers developed specially designed nanocomplexes that effectively target and kill cancer cells, including those resistant to traditional treatments.

Taking lessons from an eye-opening stint in industry, Sean Chia is tackling the challenges of biotherapeutics manufacturing to help bring game-changing antibody treatments to more patients.

A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are also easily scalable in manufacturing settings.

Researchers develop an analytical technique to combat food fraud by accurately profiling and differentiating meat samples based on their unique glycan profiles.

A new method to remove a toxic compound from cottonseed could unlock a readily available source of nutritious plant-based protein.

A*STAR researchers develop a high-efficiency technique for scaling up stem cell manufacturing for clinical and research applications.

Leveraging on its public sector and industry collaborations, A*STAR and the Experimental Drug Development Centre hold the keys to effective drug discovery and development.

A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.